Department of Experimental Medicine, Faculty of Medicine, McGill University, Montréal, QC H4A 3J1, Canada.
Lady Davis Research Institute, Jewish General Hospital, Montréal, QC H3T 1E2, Canada.
Proc Natl Acad Sci U S A. 2022 Sep 6;119(36):e2203452119. doi: 10.1073/pnas.2203452119. Epub 2022 Aug 29.
The contribution of deregulated chromatin architecture, including topologically associated domains (TADs), to cancer progression remains ambiguous. CCCTC-binding factor (CTCF) is a central regulator of higher-order chromatin structure that undergoes copy number loss in over half of all breast cancers, but the impact of this defect on epigenetic programming and chromatin architecture remains unclear. We find that under physiological conditions, CTCF organizes subTADs to limit the expression of oncogenic pathways, including phosphatidylinositol 3-kinase (PI3K) and cell adhesion networks. Loss of a single CTCF allele potentiates cell invasion through compromised chromatin insulation and a reorganization of chromatin architecture and histone programming that facilitates de novo promoter-enhancer contacts. However, this change in the higher-order chromatin landscape leads to a vulnerability to inhibitors of mTOR. These data support a model whereby subTAD reorganization drives both modification of histones at de novo enhancer-promoter contacts and transcriptional up-regulation of oncogenic transcriptional networks.
染色质结构失调(包括拓扑相关结构域[TAD])对癌症进展的影响仍不明确。CCCTC 结合因子(CTCF)是高级染色质结构的重要调节剂,超过一半的乳腺癌中都存在 CTCF 拷贝数缺失,但该缺陷对表观遗传编程和染色质结构的影响尚不清楚。我们发现,在生理条件下,CTCF 组织亚 TAD 以限制致癌途径(包括磷脂酰肌醇 3-激酶[PI3K]和细胞黏附网络)的表达。单个 CTCF 等位基因的缺失通过削弱染色质隔离和染色质结构及组蛋白编程的重排来促进细胞侵袭,从而促进新启动子增强子接触。然而,这种高级染色质景观的变化导致对 mTOR 抑制剂的敏感性增加。这些数据支持了这样一种模型,即亚 TAD 重排既驱动了新的增强子-启动子接触处组蛋白的修饰,又驱动了致癌转录网络的转录上调。